SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024969
Filing Date
2021-05-06
Accepted
2021-05-06 16:12:20
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q - Q1/2021 ctmx-10q_20210331.htm   iXBRL 10-Q 2462516
2 EX-10.2 - BMS AMENDMENT 2 ctmx-ex102_137.htm EX-10.2 66657
3 EX-10.3 - FUCHS CONSULTING AGREEMENT ctmx-ex103_136.htm EX-10.3 39060
4 EX-31.1 ctmx-ex311_10.htm EX-31.1 19576
5 EX-31.2 ctmx-ex312_9.htm EX-31.2 19586
6 EX-32.1 ctmx-ex321_7.htm EX-32.1 10081
7 EX-32.2 ctmx-ex322_8.htm EX-32.2 10403
8 GRAPHIC guca3cel2yty000001.jpg GRAPHIC 21118
9 GRAPHIC guca3cel2yty000002.jpg GRAPHIC 87536
  Complete submission text file 0001564590-21-024969.txt   8255869

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20210331.xsd EX-101.SCH 55111
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20210331_cal.xml EX-101.CAL 49576
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20210331_def.xml EX-101.DEF 182408
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20210331_lab.xml EX-101.LAB 380664
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20210331_pre.xml EX-101.PRE 323293
15 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-10q_20210331_htm.xml XML 1344683
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 21897889
SIC: 2834 Pharmaceutical Preparations